An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted a personal account about using two branded weight-loss drugs and feeling frustrated. They say they started Wegovy (a marketed form of semaglutide) a year ago and lost a lot of weight quickly at first — about 23 kg in five months — then hit a long plateau. Wegovy later caused major sleep disruption for them, so they switched to Mounjaro (tirzepatide). That led to another small loss (about 4 kg) and then another plateau. They’re now 135 kg, down from 163 kg, but paying about €400 a month and feeling like they aren’t getting further results. Wegovy is the brand name for semaglutide at a dose used to treat obesity. Semaglutide acts like a hormone your gut makes after eating that tells your brain you’re full and slows how fast your stomach empties. Mounjaro is the brand name for tirzepatide, which hits two similar appetite-related pathways at once. Both are injectable prescription drugs that reduce appetite and can lead to substantial weight loss for many people when combined with lifestyle changes. This account is a single-person report, not a clinical study. The pattern described — fast early weight loss, then a plateau — is common in the research on these drugs. Trials show many people lose significant weight in the first months, and the pace usually slows over time. Side effects like nausea, stomach upset, and sometimes sleep problems are reported, though severe sleep disruption is less commonly emphasized in trials; individual responses vary. Switching from one drug to another can produce additional weight loss for some, but it’s not guaranteed and may only yield small gains for others. Why this matters to a regular person: these drugs can be powerful tools for weight loss, but they are not magic cures. If you or someone you know is considering them, expect the biggest changes early on and plan for a possible plateau. Costs can be high, and insurance coverage varies, so the financial burden is real for many. Also, side effects can affect quality of life in ways that aren’t just numbers on the scale — sleep, digestion, and mood can change and that matters. Caveats and risks: this post is anecdote-level evidence — useful for perspective but not proof of how the drugs work for most people. Clinical trials provide broader data but still can’t predict every individual’s outcome. Common side effects include nausea, diarrhea, constipation, and sometimes low blood sugar in people who also use diabetes medications. Sudden or severe side effects should prompt medical advice. These drugs are prescription-only; they should be started and monitored by a clinician. Stopping them often leads to some weight regain, which is another practical consideration. Bottom line: these medications can produce strong early weight loss for many, but plateaus, side effects, cost, and variable individual responses mean they’re not a guaranteed or permanent fix.
Source: r/Semaglutide